Your browser doesn't support javascript.
loading
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations in conjunction with systemic lupus erythematosus: Missed diagnosis or misdiagnosis?
Wang, Xinhui; Su, Li; Han, Jinming; Han, Yilai; Yin, Yunsi; Huang, Jiancheng; Tang, Yi; Zhao, Yi; Qin, Qi.
Afiliación
  • Wang X; Department of Geriatrics, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, China.
  • Su L; Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, China.
  • Han J; Department of Rheumatology and Allergy, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Han Y; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Yin Y; Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Huang J; Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, China.
  • Tang Y; International School, Capital Medical University, Beijing, China.
  • Zhao Y; Innovation Center for Neurological Disorders, Department of Neurology, Xuanwu Hospital, Capital Medical University, National Center for Neurological Disorders, Beijing, China.
  • Qin Q; Department of Rheumatology and Allergy, Xuanwu Hospital, Capital Medical University, Beijing, China.
Immun Inflamm Dis ; 12(8): e1367, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39119967
ABSTRACT

BACKGROUND:

Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is a rare autosomal dominant systemic microvascular disorder attributed to TREX1 (three-prime repair exonuclease-1) gene mutations, often proned to misdiagnosed.

METHODS:

We reported a case of RVCL-S coexisting with systemic lupus erythematosus due to a mutation in the TREX1 gene. This study provided a summary and discussion of previously documented cases related to TREX1 mutations or RVCL-S.

RESULTS:

A 39-year-old female patient visited the clinic due to progressive memory loss and speech difficulties. Magnetic resonance imaging results showed corpus callosum atrophy and multiple subcortical calcifications in both brain hemispheres. Genetic testing revealed a TREX1 gene mutation (c.294dupA). Treatment with immunosuppressive therapy for 2 months led to improvements in communication and mobility. We also summarized previously reported cases providing an overview of TREX1 gene mutation or RCVL-S.

CONCLUSION:

Our case establishes a compelling foundation for future RVCL-S diagnosis and treatment paradigms. Notably, conducting systemic immunity screening in patients with RVCL-S emerges as a strategic approach to prevent potential diagnostic oversights.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Exodesoxirribonucleasas / Leucoencefalopatías / Lupus Eritematoso Sistémico / Mutación Límite: Adult / Female / Humans Idioma: En Revista: Immun Inflamm Dis Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Exodesoxirribonucleasas / Leucoencefalopatías / Lupus Eritematoso Sistémico / Mutación Límite: Adult / Female / Humans Idioma: En Revista: Immun Inflamm Dis Año: 2024 Tipo del documento: Article País de afiliación: China